Regulatory Consultancy

Dr. Novack continued to work with numerous clients in providing regulatory guidance. In 2011, this included many meetings with FDA’s CDER to discuss the development of novel therapeutics.

Dr. Novack selected to serve on the Glaucoma Research Society

Dr. Novack was selected as a member of the Glaucoma Research Society, a public interest, nonprofit scientific association of outstanding glaucoma researchers. The society provides a forum to discuss and stimulate compelling research to prevent glaucoma-related disability worldwide; the organization consists of fewer than 100 scientists whose investigations lead the field of glaucoma.